✦ LIBER ✦

Management of relapsing–remitting multiple sclerosis in Latin America: Practical recommendations for treatment optimization

✍ Scribed by Correale, Jorge; Abad, Patricio; Alvarenga, Regina; Alves-Leon, Soniza; Armas, Elizabeth; Barahona, Jorge; Buzó, Ricardo; Corona, Teresa; Cristiano, Edgardo; Gracia, Fernando; Bonitto, Juan García; Macías, Miguel Angel; Soto, Arnoldo; Vizcarra, Darwin; Freedman, Mark S.

Book ID: 121842600
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 677 KB
Volume: 339
Category: Article
ISSN: 0022-510X
DOI: 10.1016/j.jns.2014.02.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PND11 Budget Impact Analysis of First-Li

PND11 Budget Impact Analysis of First-Line Treatment for Relapsing – Remitting Multiple Sclerosis in Spain

✍ R. Sánchez-de la Rosa; E. Sabater; M.A. Casado 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PND23 Economic Evaluation of Natalizumab

PND23 Economic Evaluation of Natalizumab Versus Fingolimod for the Treatment of Relapsing-Remitting Multiple Sclerosis in Sweden

✍ S.T. Alexopoulos; B. Deniz; A.R. Walker; R. Arnold; D. Bates 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

The Cost Effectiveness of BG-12 (Dimethy

The Cost Effectiveness of BG-12 (Dimethyl Fumarate) for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada

✍ Su, W.; Walker, A.; Sarda, S.; Kansal, A.R.; Vicente, C.; Deniz, B. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Cost analysis of glatiramer acetate vs.

Cost analysis of glatiramer acetate vs. fingolimod for the treatment of patients with relapsing-remitting multiple sclerosis in Spain

✍ Rainel Sanchez-de la Rosa, Eliazar Sabater, Miguel A Casado 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 206 KB

The Budget Impact of Introducing Bg-12 (

The Budget Impact of Introducing Bg-12 (Dimethyl Fumarate) for Treatment of Relapse-Remitting Multiple Sclerosis (RRMS) in Canada

✍ Dorman, E.; Kansal, A.R.; Sarda, S. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PND30 Cost Analysis of Glatiramer Acetat

PND30 Cost Analysis of Glatiramer Acetate Versus Fingolimod for the Treatment of Patients With Relapsing-Remitting Multiple Sclerosis in Spain

✍ Sánchez-de la Rosa, R.; Sabater, E.; Casado, M.A. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB